Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Association between OCT1 gene polymorphisms and gastrointestinal intolerance to metformin among Thai diabetic patients
TCTR20200218001Completed
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoint: Association between OCT1 polymorphisms and metformin GI intolerance. Started Aug 2018; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20200218001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200218001.